Observational analysis evaluates the effect of fremanezumab on migraine days in adults, suggesting timely treatment improves outcomes.
Evaluation of the impact of migraine type (episodic or chronic; EM, CM), number of prior preventive treatment failures and treatment pauses on the reduction of monthly migraine days (MMD) induced by fremanezumab treatment among adults enrolled in the 24-month, observational, prospective, Phase 4 PEARL study.
No takes yet. Share an insight, caveat, or question.
Martins et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: